Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. - See more at:

Research Grants show all


Patents show all

Gilead has 3 licensable patents.

Clinical Trials show all

205Phase 2182Phase 3113Phase 496Phase 159N/A42Other

SEC Filings show all


Contact Information

    SEC Form D Funding Events

    2006-04-03UnknownUnknownOther (Paper Filing)